The tradespeople-focused retailer is struggling. Is there any hope for investors?
Shares sink after the company announces a management shakeup and cuts its full-year guidance. Here's what investors need to know.
Looking for safety in uncertain times? These three healthcare stocks might be a perfect fit.
Shares sink after the company reports disappointing quarterly results and provides downbeat guidance. Here are the must-know details for investors.
Shares drop after management announces a surprise capital raise. Here's what investors need to know.
Shares jump after a Wall Street pro turns bullish.
Shares tank after the company receives an analyst downgrade and an SEC filing reveals that an important insider has been selling.
Investors bid up the share price after the company received some bullish praise from a Wall Street pro.
Shares sink after the newly public company reports mixed quarterly results.
Shares jump after the software-as-a-service provider reports upbeat quarterly results.
Shares drop after management cuts its full-year profit guidance. What's going on?
The company closed on its acquisition of WageWorks and is now the largest HSA administrator in the country.
Though the company delivered positive news, so what could explain its stock price tumble?
Shares jump after the clinical-stage biotech reports encouraging results from an important late-stage trial.
ShockWave and Guardant reported fantastic things, while Abiomed and Inogen dropped precipitously on some scary updates.
The semiconductor software specialist raises its full-year guidance again after another strong quarter.
This newly public company is growing at breakneck speed and has a massive opportunity ahead of it.
Shares continue to rebound after an SEC filing reveals that an insider has been quietly adding to his position.
The cloud-based software maker snags a buyout offer.
Shares jump after the newly public medical-device company reports upbeat earnings.